ETOPOSIDE MYLAN
ETOPOSIDE
Public price
1.465,00 MAD
Reimbursement base
1.465,00 MAD
Active substance
ETOPOSIDE
Reimbursable
What is this medicine?
ETOPOSIDE MYLAN contains ETOPOSIDE. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
ETOPOSIDE, SOLUTION A DILUER POUR PERFUSION, 20 MG, 10 FLACON 10 ML
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
ANTINEOPLASIQUE CYTOTOXIQUE - G
Availability note
Reimbursable
Hospital price
1.200,00 MAD
Strength
20 MG
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
10 FLACON 10 ML
Type
G
Therapeutic class
ANTINEOPLASIQUE CYTOTOXIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 1.465,00 MAD
Available presentations and strengths
Medicines with the same active substance
ETOPOSIDE
100 MG · 1 BOITE 1 FLACON
0,00 MAD
ETOPOSIDE COOPER
50 MG · 1 BOITE 10 CAPSULE
0,00 MAD
ETOPOSIDE COOPER
50 MG · 1 BOITE 4 CAPSULE
0,00 MAD
VEPESIDE
100 MG · 1 BOITE 5 FLACON
0,00 MAD
ETOPOSIDE EBEWE
20 MG · 1 FLACON 2.5 ML
62,00 MAD
ETOPOSIDE EBEWE
20 MG / ML · FLACON DE 2,5 ML
62,00 MAD
ETOPOSIDE COOPER
100 MG · 1 BOITE 1 FLACON
118,00 MAD
ETOPOSIDE COOPER
100 MG / 5 ML · BOITE DE 1 FLACON DE 5 ML
118,00 MAD
ETOPOSIDE EBEWE
20 MG · 1 FLACON 5 ML
118,00 MAD
ETOPOSIDE EBEWE
20 MG / ML · FLACON DE 5 ML
118,00 MAD
ETOSIDE
100 MG / 5 ML · 1 FLACON DE 5 ML
122,00 MAD
ETOSIDE 100 MG / 5 ML
100 MG / 5 ML · 1 flacon de 5 ML
122,00 MAD